These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 9061508

  • 1. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
    Bernini GP, Brogi G, Vivaldi MS, Argenio GF, Sgrò M, Moretti A, Salvetti A.
    J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
    [Abstract] [Full Text] [Related]

  • 2. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
    Patócs A, Tóth M, Barta C, Sasvári-Székely M, Varga I, Szücs N, Jakab C, Gláz E, Rácz K.
    Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
    [Abstract] [Full Text] [Related]

  • 3. Twenty-four hour 17-hydroxyprogesterone response to adrenocorticotropine in adrenal incidentalomas: augmented response after adrenalectomy in two patients.
    Kamel N, Erdoğan MF, Tonyukuk V, Ilgin SD, Erdoğan G.
    Endocr J; 2002 Feb; 49(1):35-40. PubMed ID: 12008748
    [Abstract] [Full Text] [Related]

  • 4. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T, Schlaghecke R.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - hormonal and mutation screening.
    Wagnerova H, Lazúrová I, Habalová V, Dudásová D, Vrzgula A.
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):272-5. PubMed ID: 18589890
    [Abstract] [Full Text] [Related]

  • 6. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
    Ozgen AG, Bayraktar F, Yilmaz C.
    Endocr Pract; 2001 May; 7(6):448-53. PubMed ID: 11747281
    [Abstract] [Full Text] [Related]

  • 7. Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome.
    Dall'Asta C, Barbetta L, Libé R, Passini E, Ambrosi B.
    Horm Res; 2002 May; 57(5-6):192-6. PubMed ID: 12053092
    [Abstract] [Full Text] [Related]

  • 8. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
    Pham-Huu-Trung MT, Gourmelen M, Raux-Eurin MC, Girard F.
    J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
    [Abstract] [Full Text] [Related]

  • 9. Increased 17 alpha-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect?
    Del Monte P, Bernasconi D, Bertolazzi L, Meozzi M, Badaracco B, Torre R, Marugo M.
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):273-7. PubMed ID: 7758232
    [Abstract] [Full Text] [Related]

  • 10. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [Abstract] [Full Text] [Related]

  • 11. Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'.
    Reincke M, Peter M, Sippell WG, Allolio B.
    Eur J Endocrinol; 1997 Feb; 136(2):196-200. PubMed ID: 9116915
    [Abstract] [Full Text] [Related]

  • 12. A contribution to the classification of cases of non-classic 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Phocas I, Chryssikopoulos A, Sarandakou A, Rizos D, Trakakis E.
    Gynecol Endocrinol; 1995 Sep; 9(3):229-38. PubMed ID: 8540293
    [Abstract] [Full Text] [Related]

  • 13. Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden.
    Sahlander F, Bensing S, Falhammar H.
    Front Endocrinol (Lausanne); 2022 Sep; 13():1017303. PubMed ID: 36545328
    [Abstract] [Full Text] [Related]

  • 14. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone.
    Turton DB, O'Brian JT, Shakir KM.
    J Endocrinol Invest; 1992 Dec; 15(11):789-96. PubMed ID: 1337905
    [Abstract] [Full Text] [Related]

  • 15. Increased plasma 17-hydroxyprogesterone response to ACTH in patients with nonhyperfunctioning adrenal adenomas is not due to a deficiency in 21-hydroxylase activity.
    Tóth M, Rácz K, Gláz E.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3756-7. PubMed ID: 9768700
    [No Abstract] [Full Text] [Related]

  • 16. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.
    Grossrubatscher E, Vignati F, Possa M, Lohi P.
    J Endocrinol Invest; 2001 Dec; 24(11):846-55. PubMed ID: 11817708
    [Abstract] [Full Text] [Related]

  • 17. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 18. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 19. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
    Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macrì C, Boscaro M.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):55-62. PubMed ID: 9435416
    [Abstract] [Full Text] [Related]

  • 20. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.